A detailed history of Ahrens Investment Partners LLC transactions in Bionano Genomics, Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 1,250 shares of BNGO stock, worth $275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,250
Holding current value
$275
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$1.06 - $1.97 $1,325 - $2,462
1,250 New
1,250 $1,000
Q4 2021

Jan 21, 2022

BUY
$29.9 - $61.2 $37,375 - $76,500
1,250 New
1,250 $4,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $63.8M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.